Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus

References

• SchaferAIThe hypercoagulable statesAnn Intern Med19851028148183158262
   PubMed Web of Science ®Google Scholar
• FradeLJGde la CalleHAlavaIDiabetes as a hypercoagulable state: its relationship with fibrin fragments and vascular damageThromb Res1987475335403118498
   PubMed Web of Science ®Google Scholar
• NomuraSOzakiYIkedaYFunction and role of microparticles in various clinical settingsThromb Res200812382318667228
   PubMed Web of Science ®Google Scholar
• CominaciniLPasiniAFGarbinUElevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic controlDiabetologia199538112211248591829
   PubMed Web of Science ®Google Scholar
• LimYCSnappKKansasGSImportant contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-α-activated endothelium under flow in vitroJ Immunol1998161250125089725249
   PubMed Web of Science ®Google Scholar
• TschopeDEsserJSchwippertBLarge platelets circulate in an activated state in diabetesSemin Thromb Haemost199117433439
   Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSSignificance of chemokines and activated platelets in patients with diabetesClin Exp Immunol200012143744310971508
   PubMed Web of Science ®Google Scholar
• RodriguezBLLauNBurchfielCMGlucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart ProgramDiabetes Care1999221262126510480768
   PubMed Web of Science ®Google Scholar
• CoutinhoMGersteinHCWangYThe relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 yearsDiabetes Care19992223324010333939
   PubMed Web of Science ®Google Scholar
• The DECODE study group on behalf of the Europearn Diabetes Epidemiology GroupGlucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Diabetes Epidemiology: collaborative analysis of diagnostic criteria in EuropeLancet199935461762110466661
   PubMed Web of Science ®Google Scholar
• NakagamiTHyperglycaemia and mortality from all cause and from cardiovascular disease in five populations of Asian originDiabetologia20044738539414985967
   PubMed Web of Science ®Google Scholar
• ChiassonJLJosseRGGomisRAcarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trialLancet20023592072207712086760
   PubMed Web of Science ®Google Scholar
• ChiassonJLJosseRGGomisRAcarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trialJAMA200329048649412876091
   PubMed Web of Science ®Google Scholar
• HanefieldMChiassonJLKoehlerCAcarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose toleranceStroke2004351073107815073402
   PubMed Web of Science ®Google Scholar
• HanefeldMCagatayMPetrowitschTAcarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studiesEur Heart J200425101614683737
   PubMed Web of Science ®Google Scholar
• AhrHJBobergMBrendelEKrauseHPSteinkeWPharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and manArzneimittelforschung1997477347459239452
   PubMed Web of Science ®Google Scholar
• OsumiKOzekiYSaitoSDevelopment and assessment of enzyme immunoassay for platelet-derived microparticlesThromb Haemost20018532633011246556
   PubMed Web of Science ®Google Scholar
• NomuraSUehataSSaitoSEnzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndromeThromb Haemost20038950651212624635
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuATaomotoKAssessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes I JapanJ Atheroscler Thromb20091687888720032575
   PubMed Web of Science ®Google Scholar
• SimsPJFaioniEMWiedmerTComplement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activityJ Biol Chem198826318205182122848029
   PubMed Web of Science ®Google Scholar
• NomuraSSuzukiMKatsuraKPlatelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitusAtherosclerosis19951162352407575778
   PubMed Web of Science ®Google Scholar
• NomuraSTandonNNNakamuraTHigh-shear-stress- induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cellsAtherosclerosis200115827728711583705
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSEffect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetesThromb Haemost1998803883929759615
   PubMed Web of Science ®Google Scholar
• NomuraSInamiNIwasakaTPlatelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamolePlatelets20041516717215203718
   PubMed Web of Science ®Google Scholar
• NomuraSTakahashiNInamiNProbucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetesAtherosclerosis200417432933515136063
   PubMed Web of Science ®Google Scholar
• KurowskaEMNitric oxide therapies in vascular diseasesCurr Pharm Des2002815516611812265
   PubMed Web of Science ®Google Scholar
• OuchiNKiharaSAritaYNovel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein, adiponectinCirculation19991002473247610604883
   PubMed Web of Science ®Google Scholar
• ArakawaMEbatoCMitaTMiglitol suppresses the post-prandial increase in interleukin 6 and enhances active glucagons-like peptide secretion in viscerally obese subjectsMetabolism Clin Exp20085712991306
   PubMed Web of Science ®Google Scholar
• YokoyamaHKannoSIshimuraINodeKMiglitol increases adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitusMetabolism Clin Exp20085614581463
   Web of Science ®Google Scholar
• OuchiNKiharaSAritaYAdiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathwayCirculation20001021296130110982546
   PubMed Web of Science ®Google Scholar
• HottaKFunahashiTAritaYPlasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetes patientsArtherioscler Thromb Vasc Biol20002015951599
   PubMed Web of Science ®Google Scholar
• ShimabukuroMHigaNAsahiTHypoadiponectinemia is closely linked to endothelial dysfunction in manJ Clin Endocrinol Metab2003883236324012843170
   PubMed Web of Science ®Google Scholar
• ChenHMontagnaniMFunahashiTAdiponectin stimulates production of nitric oxide in vascular endothelial cellsJ Biol Chem2003278450214502612944390
   PubMed Web of Science ®Google Scholar
• HattoriYSuzukiMHattoriSGlobular adiponectin upregulates nitric oxide production in vascular endothelial cellsDiabetologia2003461543154914551684
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSCorrelation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitusThromb Res2008122394517920663
   PubMed Web of Science ®Google Scholar
• WangYLamKSChanLPost-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complexJ Biol Chem2006281163911640016621799
   PubMed Web of Science ®Google Scholar
• FülöpNMarchaseRBChathamJCRole of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular systemCardiovasc Res20077328829716970929
   PubMed Web of Science ®Google Scholar
• FülöpNMasonMMDuttaKImpact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heartAm J Physiol Cell Physiol2007292C1370C137817135297
   PubMed Web of Science ®Google Scholar
• OchiaiHOokaHShidaCAcarbose treatment increases serum total adiponectin levels in patients with type 2 diabetesEndocr J20085554955618480556
   PubMed Web of Science ®Google Scholar
• KnopFKVilsbollTLarsenSMadsbadSHolstJJKrarupTNo hypoglycemia after subcutaneous administration of glucagons-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitisDiabetes Care2003262581258712941722
   PubMed Web of Science ®Google Scholar
• PocaiACarringtonPEAdamsJRGlucagon-like peptide 1/glucagons receptor dual agonism reverses obesity in miceDiabetes2009582258226619602537
   PubMed Web of Science ®Google Scholar
• KimVhung leTHosakaTYoshidaMExendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expressionBiochem Biophys Res Commun200939061361819850014
   PubMed Web of Science ®Google Scholar